Cargando…

Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy

Low-level laser therapy has been widely used in treating many conditions, including oral mucositis. The purpose of this study was to evaluate the occurrence of oral mucositis in patients undergoing antineoplastic therapy submitted to preventive and therapeutic treatment with low-level laser therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Leite Cavalcanti, Alessandro, José de Macêdo, Dário, Suely Barros Dantas, Fernanda, dos Santos Menezes, Karla, Filipe Bezerra Silva, Diego, Alves de Melo Junior, William, Fabia Cabral Cavalcanti, Alidianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977129/
https://www.ncbi.nlm.nih.gov/pubmed/29695071
http://dx.doi.org/10.3390/jcm7050090
_version_ 1783327311453487104
author Leite Cavalcanti, Alessandro
José de Macêdo, Dário
Suely Barros Dantas, Fernanda
dos Santos Menezes, Karla
Filipe Bezerra Silva, Diego
Alves de Melo Junior, William
Fabia Cabral Cavalcanti, Alidianne
author_facet Leite Cavalcanti, Alessandro
José de Macêdo, Dário
Suely Barros Dantas, Fernanda
dos Santos Menezes, Karla
Filipe Bezerra Silva, Diego
Alves de Melo Junior, William
Fabia Cabral Cavalcanti, Alidianne
author_sort Leite Cavalcanti, Alessandro
collection PubMed
description Low-level laser therapy has been widely used in treating many conditions, including oral mucositis. The purpose of this study was to evaluate the occurrence of oral mucositis in patients undergoing antineoplastic therapy submitted to preventive and therapeutic treatment with low-level laser therapy. This cross-sectional study was carried out with 51 children and adolescents of both sexes with malignant neoplasias who developed oral mucositis and underwent low-level laser therapy. Data were collected on sex, age, type and degree of neoplasia, region affected, and remission time. 64.7% of the patients were male and were between 3 and 6 years of age (39.2%). Acute lymphoid leukemia was the most frequent neoplasm (37.3%). Regarding the maximum oral mucositis, grade 2 (41.2%) was predominant, with jugal mucosa (29.9%) and tongue (17.7%) being the most affected regions. The majority of cases presented lesion remission time between 4 and 7 days (44.0%). Most patients were young, male, and diagnosed with acute lymphoid leukemia. Predominance of grade 2 oral mucositis was observed, with jugal mucosa and tongue being the most affected regions, with the majority of cases presenting lesion remission time between 4 and 7 days. Low-level laser therapy has been shown to be an essential therapy in the prevention and treatment of these lesions, since it is a non-invasive and low-cost method.
format Online
Article
Text
id pubmed-5977129
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-59771292018-05-31 Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy Leite Cavalcanti, Alessandro José de Macêdo, Dário Suely Barros Dantas, Fernanda dos Santos Menezes, Karla Filipe Bezerra Silva, Diego Alves de Melo Junior, William Fabia Cabral Cavalcanti, Alidianne J Clin Med Article Low-level laser therapy has been widely used in treating many conditions, including oral mucositis. The purpose of this study was to evaluate the occurrence of oral mucositis in patients undergoing antineoplastic therapy submitted to preventive and therapeutic treatment with low-level laser therapy. This cross-sectional study was carried out with 51 children and adolescents of both sexes with malignant neoplasias who developed oral mucositis and underwent low-level laser therapy. Data were collected on sex, age, type and degree of neoplasia, region affected, and remission time. 64.7% of the patients were male and were between 3 and 6 years of age (39.2%). Acute lymphoid leukemia was the most frequent neoplasm (37.3%). Regarding the maximum oral mucositis, grade 2 (41.2%) was predominant, with jugal mucosa (29.9%) and tongue (17.7%) being the most affected regions. The majority of cases presented lesion remission time between 4 and 7 days (44.0%). Most patients were young, male, and diagnosed with acute lymphoid leukemia. Predominance of grade 2 oral mucositis was observed, with jugal mucosa and tongue being the most affected regions, with the majority of cases presenting lesion remission time between 4 and 7 days. Low-level laser therapy has been shown to be an essential therapy in the prevention and treatment of these lesions, since it is a non-invasive and low-cost method. MDPI 2018-04-24 /pmc/articles/PMC5977129/ /pubmed/29695071 http://dx.doi.org/10.3390/jcm7050090 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Leite Cavalcanti, Alessandro
José de Macêdo, Dário
Suely Barros Dantas, Fernanda
dos Santos Menezes, Karla
Filipe Bezerra Silva, Diego
Alves de Melo Junior, William
Fabia Cabral Cavalcanti, Alidianne
Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy
title Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy
title_full Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy
title_fullStr Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy
title_full_unstemmed Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy
title_short Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy
title_sort evaluation of oral mucositis occurrence in oncologic patients under antineoplastic therapy submitted to the low-level laser coadjuvant therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977129/
https://www.ncbi.nlm.nih.gov/pubmed/29695071
http://dx.doi.org/10.3390/jcm7050090
work_keys_str_mv AT leitecavalcantialessandro evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy
AT josedemacedodario evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy
AT suelybarrosdantasfernanda evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy
AT dossantosmenezeskarla evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy
AT filipebezerrasilvadiego evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy
AT alvesdemelojuniorwilliam evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy
AT fabiacabralcavalcantialidianne evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy